| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/10/2007 | US7202346 Where antibodies and antibody fragments recognize extracellular epitopes of plasma membrane proteins that are not released into the extracellular fluid; methods for detection, monitoring and treatment of cancer |
| 04/10/2007 | US7202345 PRO 1384 antibodies |
| 04/10/2007 | US7202344 An antibody or fragment (especially a monoclonal antibody) that binds to specific antigens for use in the diagnosis and treatment of heart, kidney and inflammatory diseases |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202340 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 04/10/2007 | US7202334 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2007 | US7202264 Supports for oligomer synthesis |
| 04/10/2007 | US7202211 Methods of preventing or treating brain ischemia or brain injury |
| 04/10/2007 | US7202093 Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds |
| 04/10/2007 | US7202092 Activated haptens useful for generating immunogens to HIV protease inhibitors; reacting indinavir sulfate in the presence of hydrogen gas and palladium catalyst to form indinavir M6 |
| 04/10/2007 | US7202091 Optically similar reference samples |
| 04/10/2007 | US7202090 Hardness measurement reagent |
| 04/10/2007 | US7202089 Early diagnosis of stroke |
| 04/10/2007 | US7202087 exploits the advantageous properties of lipids as pharmaceutical carriers in regard of gastroinstestinal uptake and/or sustained release and/or convenience and/or economy |
| 04/10/2007 | US7202082 Premature osteoblast cell line derived from the peritoneum of bone for use as models for prevention and treatment of osteoporosis |
| 04/10/2007 | US7202081 Monitoring fluorescence from mammalian progenitor cells and using adjustment in light scattering of fluorescent compounds to identify antiproliferative agents and induction of apoptosis |
| 04/10/2007 | US7202076 Label-free high-throughput optical technique for detecting biomolecular interactions |
| 04/10/2007 | US7202058 IGF-1 receptor interacting proteins |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7202055 Preparing cells for use as bioreactors for expression of heterologous polypeptides |
| 04/10/2007 | US7202054 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides |
| 04/10/2007 | US7202050 Measuring protein kinase or phosphatase activity in a sample with a reporter peptide, or a fluorescently-labeled phosphorylatable reporter peptide, cleaved by a protease, without using antibodies or radioactive labels |
| 04/10/2007 | US7202048 Identifying a thrombin generation time for a blood sample to assess risk of bleeding, to diagnose various disorders, and to monitor the effects of pharmaceutical and other treatments. |
| 04/10/2007 | US7202047 Aqueous method for determining cholesterol in remnant-like particles using cholesterol esterase, phospholipase, surfactant and cholesterol oxidase or dehydrogenase |
| 04/10/2007 | US7202046 interactions with the fluorescent ligand are then detected by means of the changes in the donor's and acceptor's excitation and/or emission energy spectra; ligands are defined as being pharmacologically significant if interaction with target protein is inhibited by the addition of non-fluorescent ligand |
| 04/10/2007 | US7202045 Detection and treatment of cancers of the lung |
| 04/10/2007 | US7202044 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents |
| 04/10/2007 | US7202043 complexing the reagent with said cells, adding the test compound at any time in relation to the complexing, allowing any endocytosis to occur, proteolytically degrading external enzyme fragment, adding protease inhibitor and the complementary member of the enzyme fragment pair and substrate |
| 04/10/2007 | US7202042 Rapid evaluation of the ratio of biological molecules |
| 04/10/2007 | US7202041 Immunoreaction measurement method |
| 04/10/2007 | US7202040 Method for screening compounds which change the binding properties of a protein with a ligand |
| 04/10/2007 | US7202037 Electrochemical sensor using intercalative, redox-active moieties |
| 04/10/2007 | US7202036 Quenching methods for background reduction in luminescence-based probe-target binding assays |
| 04/10/2007 | US7202034 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/10/2007 | US7202033 Inhibitors are identified by locking target protein kinase in inactive conformation and using covalent tethering approach to identify inhibitors preferentially targeting inactive conformation; targets for development of anticancer drugs |
| 04/10/2007 | US7202031 Co-amplifying a set of at least three microsatellite loci of genomic DNA, containing one mononucleotide repeat locus and atleast two tetranucleotide repeat loci, from the sample of genomic DNA in a multiplex amplification reaction |
| 04/10/2007 | US7202029 Nucleic acids encoding human TANGO 195 |
| 04/10/2007 | US7202025 Control of gene expression |
| 04/10/2007 | US7202024 Detecting modulators of apoptosis; provide a cell coing preferenial gene, incubate with modulator, detect adjustment in gene expression, adjustment in gene expression indicates modulatior |
| 04/10/2007 | US7202021 Antibody for use in the detection of viral protein; for use in diagnosis of creutzfeldt-jakob disease |
| 04/10/2007 | US7201908 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 04/10/2007 | US7201904 Epitopes of hepatitis C virus |
| 04/10/2007 | US7201903 Method and device for detecting feline immunodeficiency virus |
| 04/10/2007 | US7201878 For chemical analytical and immunological testing |
| 04/10/2007 | US7201876 Ion-detecting sensors comprising plasticizer-free copolymers |
| 04/10/2007 | US7201875 Fixed mounted sorting cuvette with user replaceable nozzle |
| 04/10/2007 | US7201874 System for automatically extracting and analyzing residual solvents in material samples |
| 04/10/2007 | US7201872 For determining the presence and/or concentration of biological and/or chemical substances in body; diagnosis |
| 04/10/2007 | US7201871 Blood test strips |
| 04/10/2007 | US7201866 method and an apparatus for molding a reproducible uniform concrete test sample through the use of a cap having at least one excretion hole |
| 04/10/2007 | US7201848 Methods and apparatus for separation of particles |
| 04/10/2007 | US7201836 Multiaperture sample positioning and analysis system |
| 04/10/2007 | US7201833 Integrated solid-phase hydrophilic matrix circuits and micro-arrays |
| 04/10/2007 | US7201831 Impurity detection device |
| 04/10/2007 | US7201113 Controlled dilution system for drinking water and unit therefor |
| 04/10/2007 | US7201060 Apparatus and method for determining in situ pore fluid and soil properties using multi-sensor measurement systems |
| 04/10/2007 | US7201035 Sensor arrangement |
| 04/10/2007 | CA2400361C Immortalized vascular pericyte line |
| 04/10/2007 | CA2399368C Fluorescent detection method and reagent |
| 04/10/2007 | CA2311599C Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |
| 04/10/2007 | CA2269966C Methods and reagents for determining protein s |
| 04/10/2007 | CA2254931C Human monoclonal antibodies to the hepatitis b surface antigen |
| 04/10/2007 | CA2253527C Method of assay |
| 04/10/2007 | CA2236001C Biologically active eph family ligands |
| 04/10/2007 | CA2222068C Chimeric fatty body-pro-grf analogs with increased biological potency |
| 04/10/2007 | CA2209172C Murine monoclonal anti-idiotype antibody 3h1 |
| 04/10/2007 | CA2187861C Blood glucose strip having reduced sensitivity to hematocrit |
| 04/10/2007 | CA2178308C Fluorescent labeling complexes with large stokes' shifts formed by coupling together cyanine and other fluorochromes capable of resonance energy transfer |
| 04/10/2007 | CA2173834C Monoclonal antibodies to thymidine kinase isozymes |
| 04/10/2007 | CA2169928C Bevel closure and device |
| 04/10/2007 | CA2167108C A method and device for providing and spreading fluids |
| 04/10/2007 | CA2150816C Monoclonal antibodies directed against the microtubule- associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and theirapplications |
| 04/10/2007 | CA2121599C Monoclonal antibodies directed against the microtubule-associated protein tau |
| 04/10/2007 | CA2071016C Method for detecting bovine diarrhoea virus infection nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto |
| 04/10/2007 | CA2026250C Detection and quantification of neu related proteins in the biological fluids of humans |
| 04/05/2007 | WO2007038758A2 Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition |
| 04/05/2007 | WO2007038664A1 In vitro erythroid micronucleus assay for genotoxicity |
| 04/05/2007 | WO2007038579A1 Bax expression predicts hematologic disease response to treatment |
| 04/05/2007 | WO2007038568A1 Methods for detection of fungal disease |
| 04/05/2007 | WO2007038523A2 Method of isolating analytes from a sample |
| 04/05/2007 | WO2007038501A2 Rheumatoid arthritis markers |
| 04/05/2007 | WO2007038486A2 Gamma secretase notch biomarkers |
| 04/05/2007 | WO2007038464A1 In vitro analyte sensor and methods of use |
| 04/05/2007 | WO2007038406A1 Bax expression predicts hematologic disease response to treatment |
| 04/05/2007 | WO2007037970A1 Sensor with layered electrodes |
| 04/05/2007 | WO2007037910A2 Specific removal of activated immune cells |
| 04/05/2007 | WO2007037898A2 Theramutein modulators |
| 04/05/2007 | WO2007037830A1 Method and apparatus for detecting moisture in building materials |
| 04/05/2007 | WO2007037555A1 Therapeutic or diagnostic application of dusp15 gene |
| 04/05/2007 | WO2007037550A1 Therapeutic or diagnostic application of tsta3 gene |
| 04/05/2007 | WO2007037544A1 Development of method for screening of compound capable of improving the production of regulatory t cell, and method for production of regulatory t cell using immunosuppressive macrolide antibiotic |
| 04/05/2007 | WO2007037538A1 Therapeutic or diagnostic application of spo11 gene |
| 04/05/2007 | WO2007037533A1 Therapeutic or diagnostic application of ppp1r3d gene |
| 04/05/2007 | WO2007037532A1 Therapeutic or diagnostic application of srms gene |
| 04/05/2007 | WO2007037530A1 Method of measuring biomolecular reaction at ultrahigh speed |
| 04/05/2007 | WO2007037482A1 Kit and method for use in the detection of protein-protein interaction in eukaryotic cell |
| 04/05/2007 | WO2007037473A1 Method of inhibiting cell migration and cell migration inhibitor |
| 04/05/2007 | WO2007037419A1 Method for selective, simultaneous quantification of two substances in biological sample |
| 04/05/2007 | WO2007037410A1 Method of assaying substance with affinity in sample including step of destroying blood-cell ingredient |
| 04/05/2007 | WO2007037409A1 Method of assaying substance with affinity in sample containing blood-cell ingredient |